March 31, 2011 — At a time when interaction between biopharmaceutical companies and physicians is under increased scrutiny, a recent physician survey indicates that a majority of physicians find information provided by pharmaceutical and biotech research companies and their representatives to be a valuable resource, with 94 percent of physicians reporting that information from company […]
Read moreTag: industry prescriber collaboration
industry prescriber collaboration
Regulatory/FDA
Pitts to Med Policy Pros: Academic Detailing Is Not a Panacea
Pitts to Med Policy Pros: Academic Detailing Is Not a Panacea
From : In a recent blog entry on DrugWonks.com, Peter Pitts, president of the Center for Medicine in the Public Interest, called out the federal government for putting its focus on and committing its dollars to programs that support “academic detailing,” a practice largely conducted by pharmacists to help healthcare professionals better understand medical treatment effectiveness […]
Read more
General
Coalition Focus for 2011
Coalition Focus for 2011
Although 2011 brings political party shifts in Congress and new challenges, the mission of the Coalition for Healthcare Communication (CHC) remains the same: To protect, for society and individual patients, the benefit of the free flow of healthcare information. This year the CHC will be focusing on four major issues: (1) tax treatment of marketing […]
Read moreAMA's CEJA Report Better, but Still Falls Short. Coalition Encourages Discussion and Comments
The Council on Ethical and Judicial Affairs (CEJA) of the American Medical Association (AMA) has recently submitted a report titled “Financial Relationships with Industry in Continuing Medical Education” to a reference committee of the AMA, to be considered for submission to the AMA House of Delegates on June 14th. Although the report is less stifling […]
Read more